LAVA Therapeutics N.V. (LVTX) Misses Q3 EPS by 13c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.46), $0.13 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• RBC Capital Starts GE HealthCare (GEHC) at Outperform
• Barclays Reiterates Overweight Rating on Tele2 AB (TEL2B:SS) (TLTZY)